Frequency of SOD1 and C9orf72 Gene Mutations in French ALS

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

May 15, 2023

Conditions
Amyotrophic Lateral Sclerosis
Interventions
GENETIC

Blood

a blood sample will be taken during hospitalisation for diagnostic confirmation or during the quarterly multidisciplinary consultations scheduled as part of the standard follow-up set up for these patients in the ALS centres of the FILSLAN network. If the genetic status is not yet known, this sample will be taken (1 tube of 7mL EDTA) and then sent within 24-48 hours at room temperature to one of the 3 participating molecular biology laboratories according to the criteria defined in the manual of samples being taken in the 3 laboratories.

Trial Locations (20)

13000

CHU Marseille, Marseille

14000

CHU Caen, Caen

21000

CHU Dijon, Dijon

29200

CHU de Brest, Brest

31000

CHU Toulouse, Toulouse

33000

CHU Bordeaux, Bordeaux

34000

CHU Montpellier, Montpellier

35033

CHU de Rennes, Rennes

37000

University hospital, Tours

42270

CHU St Etienne, Saint-Priest-en-Jarez

49000

CHU Angers, Angers

54000

CHU Nancy, Nancy

59000

CHU Lille, Lille

63000

CHU Clermont Ferrand, Clermont-Ferrand

67000

CHU Strasbourg, Strasbourg

69677

CHU Lyon, Bron

75000

Paris - Groupe hospitalier de la Pitié Salpetrière, Paris

87000

CHU Limoges, Limoges

97448

CHU La Réunion, Saint-Pierre

06000

CHU Nice, Nice

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

University Hospital, Tours

OTHER